United Therapeutics | UTHR - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Amarin USD 18.97M 1.03M 2025-12
Ardelyx USD 75.92M 7.69M 2025-12
Baxter International USD 728M 33M 2026-03
Bayer EUR 3.7B 356M 2026-03
BioCryst Pharmaceuticals USD 95.78M 12.77M 2025-12
Biogen USD 554.3M 128.2M 2026-03
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 39.42M 456K 2025-12
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Halozyme Therapeutics USD 46.29M 18.35M 2026-03
Insmed USD 247.26M 34.78M 2026-03
Ionis Pharmaceuticals USD 151M 21M 2026-03
J&J USD 6.03B 719M 2026-03
Lexicon Pharmaceuticals USD 3.98M 195K 2025-12
Moderna USD 173M 135M 2026-03
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 2.92B 1.16B 2026-03
PTC Therapeutics USD 73.89M 13.31M 2026-03
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 54.03M 51.35M 2026-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03
United Therapeutics USD 156.6M 34M 2026-03
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03